Humana AB (publ) (STO:HUM)
Sweden · Delayed Price · Currency is SEK 47.55
+0.60 (1.28%)
May 6, 2026, 5:29 PM CET
Humana AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 9,955 | 10,011 | 10,295 | 9,638 | 9,199 | 8,176 |
Other Revenue | 4 | 5 | 1 | 3 | 4 | 10 |
| 9,959 | 10,016 | 10,296 | 9,641 | 9,203 | 8,186 | |
Revenue Growth (YoY) | -4.45% | -2.72% | 6.79% | 4.76% | 12.42% | 5.34% |
Cost of Revenue | 7,829 | 7,883 | 8,025 | 7,530 | 7,253 | 6,333 |
Gross Profit | 2,130 | 2,133 | 2,271 | 2,111 | 1,950 | 1,853 |
Selling, General & Admin | 1,084 | 1,084 | 1,184 | 1,200 | 1,082 | 926 |
Other Operating Expenses | 6 | 2 | -1 | -8 | - | - |
Operating Expenses | 1,672 | 1,674 | 1,766 | 1,730 | 1,536 | 1,346 |
Operating Income | 458 | 459 | 505 | 381 | 414 | 507 |
Interest Expense | -220 | -230 | -284 | -248 | -166 | -138 |
Interest & Investment Income | 7 | 12 | 14 | 17 | 7 | 1 |
Currency Exchange Gain (Loss) | - | - | -3 | 9 | -3 | -1 |
Other Non Operating Income (Expenses) | -37 | - | - | - | -3 | -1 |
EBT Excluding Unusual Items | 208 | 241 | 232 | 159 | 249 | 368 |
Merger & Restructuring Charges | - | - | -20 | - | -1 | -15 |
Gain (Loss) on Sale of Assets | 48 | 48 | -13 | 2 | -9 | - |
Asset Writedown | - | - | - | - | -3 | - |
Other Unusual Items | - | - | -4 | 70 | 38 | 1 |
Pretax Income | 256 | 289 | 195 | 231 | 274 | 354 |
Income Tax Expense | 54 | 52 | 50 | 53 | 64 | 78 |
Earnings From Continuing Operations | 202 | 237 | 145 | 178 | 210 | 276 |
Minority Interest in Earnings | -2 | -1 | -1 | -2 | - | - |
Net Income | 200 | 236 | 144 | 176 | 210 | 276 |
Net Income to Common | 200 | 236 | 144 | 176 | 210 | 276 |
Net Income Growth | 1.52% | 63.89% | -18.18% | -16.19% | -23.91% | 5.34% |
Shares Outstanding (Basic) | 49 | 50 | 50 | 48 | 48 | 49 |
Shares Outstanding (Diluted) | 49 | 50 | 50 | 48 | 48 | 49 |
Shares Change (YoY) | -3.87% | -0.47% | 4.89% | -0.28% | -1.51% | -8.11% |
EPS (Basic) | 4.07 | 4.73 | 2.87 | 3.68 | 4.38 | 5.67 |
EPS (Diluted) | 4.07 | 4.73 | 2.87 | 3.68 | 4.38 | 5.67 |
EPS Growth | 5.61% | 64.66% | -22.00% | -15.95% | -22.74% | 14.64% |
Free Cash Flow | 660 | 666 | 570 | 451 | 441 | 572 |
Free Cash Flow Per Share | 13.45 | 13.34 | 11.36 | 9.43 | 9.20 | 11.75 |
Dividend Per Share | 1.350 | 1.350 | 1.000 | - | - | - |
Dividend Growth | 35.00% | 35.00% | - | - | - | - |
Gross Margin | 21.39% | 21.30% | 22.06% | 21.90% | 21.19% | 22.64% |
Operating Margin | 4.60% | 4.58% | 4.91% | 3.95% | 4.50% | 6.19% |
Profit Margin | 2.01% | 2.36% | 1.40% | 1.83% | 2.28% | 3.37% |
Free Cash Flow Margin | 6.63% | 6.65% | 5.54% | 4.68% | 4.79% | 6.99% |
EBITDA | 553 | 552 | 584 | 458 | 478 | 570 |
EBITDA Margin | 5.55% | 5.51% | 5.67% | 4.75% | 5.19% | 6.96% |
D&A For EBITDA | 95 | 93 | 79 | 77 | 64 | 63 |
EBIT | 458 | 459 | 505 | 381 | 414 | 507 |
EBIT Margin | 4.60% | 4.58% | 4.91% | 3.95% | 4.50% | 6.19% |
Effective Tax Rate | 21.09% | 17.99% | 25.64% | 22.94% | 23.36% | 22.03% |
Revenue as Reported | 9,970 | 10,070 | 10,302 | 9,728 | 9,241 | 8,188 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.